UK Launches Inquiry Into Its Clinical Trials Problems After Pharma Outcry

Ex-Health Minister To Report Back In Spring

 
• By Andrew McConaghie

Stung by criticism from the AstraZeneca and GSK CEOs, the UK government has launched an independent review into commercial clinical trials in the hopes of reversing a steep decline.

NHS
Delays to clinical trial initiation and poor recruitment levels are endangering the UK's status as a leading nation for commercial research. • Source: Shutterstock

More from Clinical Trials

More from R&D